Preclinical and Early Clinical Development of a GATA-3-Specific Dnazyme Intended for the Treatment of Th2-Driven Asthma

被引：0
|
作者：
Turowska, Agnieszka [1 ]
Homburg, Ursula [1 ]
Kuhlmann, Jens [1 ]
Mueller, Anke [1 ]
Bille, Joachim [1 ]
Renz, Harald E. [2 ]
Garn, Holger [2 ]
机构：
[1] Sterna Biol GmbH & Co KG, Marburg, Germany
[2] Univ Marburg, Marburg, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.683
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB2 / AB2
页数：1
相关论文
共 23 条
  • [1] Advantageous toxicity profile of an inhaled GATA-3-specific DNAzyme intended for anti-inflammatory treatment of Th2-driven asthma
    Fuhst, Rainer
    Runge, Frank
    Buschmann, Jochen
    Praechter, Christiane
    von Erichsen, Jasmin
    Turowska, Agnieszka
    Hoymann, Heinz-Gerd
    Mueller, Meike
    Pohlmann, Gerhard
    Sewald, Katherina
    Ziemann, Christina
    Schlueter, Gerhard
    Garn, Holger
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Gata-3-specific dnazyme as an appraoch for asthma-therapy - Abstracts
    Dicke, T.
    Wegmann, M.
    Sel, S.
    Renz, H.
    Garn, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S1 - S1
  • [3] GATA-3-specific DNAzyme - A novel approach for stratified asthma therapy
    Garn, Holger
    Renz, Harald
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (01) : 22 - 30
  • [4] Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma
    Homburg, Ursula
    Renz, Harald
    Timmer, Wolfgang
    Hohlfeld, Jens M.
    Seitz, Friedeborg
    Lueer, Katrin
    Mayer, Alexandra
    Wacker, Anja
    Schmidt, Oliver
    Kuhlmann, Jens
    Turowska, Agnieszka
    Roller, Julia
    Kutz, Klaus
    Schlueter, Gerhard
    Krug, Norbert
    Garn, Holger
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (03) : 797 - +
  • [5] Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme
    Sel, Serdar
    Wegmann, Michael
    Dicke, Tanja
    Sel, Sarper
    Henke, Wolfgang
    Yildirim, Ali Oe.
    Renz, Harald
    Garn, Holger
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (04) : 910 - 916
  • [6] Safety Profile And Pharmacokinetics Of An Inhaled Gata-3-Specific Dnazyme In Phase I Clinical Trials In Healthy Subjects And Patients With Allergic Asthma
    Homburg, U.
    Bille, J.
    Kuhlmann, J.
    Turowska, A.
    Renz, H.
    Garn, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma
    Hohlfeld, Jens
    Lueer, Katrin
    Krug, Norbert
    Turowska, Agnieszka
    Renz, Harald
    Garn, Holger
    Homburg, Ursula
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Long-lasting anti-inflammatory effects of a GATA-3-specific DNAzyme in acute and chronic experimental asthma models
    Garn, H.
    Wegmann, M.
    Dicke, T.
    Sel, S.
    Renz, H.
    ALLERGY, 2007, 62 : 101 - 101
  • [9] Treatment effects of a GATA-3-specific DNAzyme on disease progression in a subacute oxazolone-induced mouse model of atopic dermatitis
    Purath, U.
    Ibrahim, R.
    Turowska, A.
    Homburg, U.
    Runkel, F.
    Schmidts, T.
    Dobler, D.
    Renz, H.
    Garn, H.
    Mueller, A.
    ALLERGY, 2014, 69 : 49 - 50
  • [10] Safety profile and pharmacokinetics of SB010, an inhaled GATA-3-specific DNAzyme, in phase I clinical trials in healthy and asthmatic subjects
    Homburg, Ursula
    Turowska, Agnieszka
    Kuhlmann, Jens
    Mueller, Anke
    Renz, Jonas
    Bille, Joachim
    Renz, Harald
    Garn, Holger
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
123